Oscar Health experienced significant revenue growth in Q3 2025, reaching $2.986 billion, primarily driven by higher membership. However, the company reported increased losses, with a net loss of $137.5 million and an Adjusted EBITDA loss of $101.5 million, largely due to an increase in the net risk adjustment transfer accrual. Despite the losses, the SG&A expense ratio improved due to greater fixed cost leverage and disciplined cost management.

Oscar Health's Q2 2025 results showed revenue growth due to increased membership, but profitability suffered from higher medical costs and adverse market conditions.

Oscar Health saw substantial revenue growth driven by higher membership, accompanied by improved operating and net income margins.

Oscar Health announced its Q4 and full year 2024 results, reporting positive Adjusted EBITDA and net income profitability for the first time in company history. The company's revenue reached $9.2 billion for the year, driven by membership growth and strong retention.

Oscar Health announced positive third quarter results, demonstrating strong revenue growth and improved financial performance. The company is updating its full year 2024 outlook to reflect year-to-date performance and expects to deliver positive adjusted EBITDA and net income profitability this year.

Oscar Health reported strong second quarter results with robust revenue growth, improved operating margin, and strong bottom line performance. The company updated its full year 2024 guidance, projecting revenue to be in the $9.0 billion to $9.1 billion range and Adjusted EBITDA to be in the $160 million to $210 million range.

Oscar Health, Inc. announced its financial results for the first quarter ended March 31, 2024, with total revenue of $2.1 billion, a 46% increase year-over-year. The company reported a net income attributable to Oscar of $177.4 million, or $0.62 of diluted earnings per share.

Oscar Health announced strong Q4 and full-year 2023 results, with core metrics exceeding expectations. The company delivered on its commitment for Insurance Company Adjusted EBITDA profitability and anticipates consolidated Adjusted EBITDA profitability in 2024. They served over 1.3 million members and are focused on sustainable margin expansion.

Oscar Health announced its financial results for Q3 2023, showcasing significant year-over-year improvements across core ratios. The company is raising its full year outlook for 2023 InsuranceCo Adjusted EBITDA and consolidated Adjusted EBITDA, projecting profitability in its insurance business in 2023 and Total Company Adjusted EBITDA profitability in 2024.

Oscar Health, Inc. reported strong financial results for the second quarter ended June 30, 2023. Premiums earned increased by 48% year-over-year, and the net loss improved by $96.7 million year-over-year. The company is reaffirming its full year 2023 outlook.

Oscar Health reported a solid first quarter with significant year-over-year improvements. Premiums earned increased by 50% to $1.4 billion, and the net loss improved by $37.7 million to $39.6 million. Adjusted EBITDA also saw substantial improvement, reaching $51.1 million.

Oscar Health's Q4 2022 results demonstrated significant year-over-year improvement in core operating margins. The company's focus on cost management and administrative efficiency has positioned it well for future profitability.

Oscar Health reported an 81% year-over-year increase in membership, reaching 1,075,445 members as of September 30, 2022. The company's premiums earned increased by 116% year-over-year, and the Medical Loss Ratio (MLR) improved by 980 bps to 89.9%. Oscar Health is now targeting Total Company profitability in 2024, a year earlier than previously expected.

Oscar Health announced its Q2 2022 financial results, highlighted by an 84% year-over-year increase in membership, reaching 1,036,720. The company reported premiums earned of $995 million, an 88% increase YoY, and a net loss of $112 million, which increased by $39 million YoY. Oscar Health is reaffirming its 2022 outlook across all metrics and remains focused on achieving profitability for its Insurance product in 2023.

Oscar Health announced its Q1 2022 financial results, showing significant growth in premiums and membership. The company reported a net loss of $77 million but reaffirmed its 2022 outlook across all metrics.

Oscar Health, Inc. announced its financial results for the fourth quarter and year ended December 31, 2021. The company had a strong performance in Q4 2021, meeting or exceeding expectations across key metrics. Membership as of December 31, 2021 was 598,169, a 49% increase YoY.